Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?

Authors

  • Jehonathan H. Pinthus
  • Wilhelmina C. Duivenvoorden

DOI:

https://doi.org/10.5489/cuaj.4394

Downloads

Download data is not yet available.

Downloads

Published

2017-02-20

How to Cite

Pinthus, J. H., & Duivenvoorden, W. C. (2017). Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?. Canadian Urological Association Journal, 11(1-2), 39–40. https://doi.org/10.5489/cuaj.4394